Novartis AG ADR(NVS)
81.83
Change: 0 (0)
As of Wed 10/06/2021 03:01 AM% Of Value
Growth
Value Per Share
:
:
:
414.12
5.97
19.7600 (as of 19/07/2019)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
| Open | 91.57 | Dividend | 2400 |
| Close Price | 81.83 | DivYield | 3.4 % |
| High | 91.68 | Growth | 0.0 |
| Low | 91.24 | Growth% | 5.97 |
| P/e | 15.869 | Volume | 2.9 M |
| P/b | 2.8 | Market Capital | 184.6 B |
| Highest High | 86.65 | Lowest Low | 67.59 |
| 50 Days Moving Average | 87.69 (as of 18/07/2019) | 50 Days Moving Average Percentage | -1.804 (as of 18/07/2019 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 50.1 B | 53.1 B | 48.6 B | 49.8 B | 52.8 B |
| Cap Spending | -1.6 B | -1.6 B | -522.0 M | -1.1 B | -1.1 B |
| Operating Expenses | 24.3 B | 26.5 B | 25.1 B | 24.6 B | 25.3 B |
| Operating Cash Flow | 8.6 B | 8.1 B | 9.0 B | 10.1 B | 11.6 B |
| Free Cash Flow | 11.0 B | 12.6 B | 13.1 B | 12.4 B | 13.9 B |
| Free Cash Flow Per Share | 4.745 | 5.455 | 5.719 | 5.473 | 6.228 |
| Total liabilities | 28.5 B | 32.1 B | 29.3 B | 38.0 B | 31.0 B |
| Total cash | 8.8 B | 13.2 B | 11.1 B | 9.6 B | 12.4 B |
| ROE% | 0.108 | 0.166 | 0.227 | 0.15 | 0.42 |
| Outstanding Shares | 2.3 B | 2.3 B | 2.2 B | 2.2 B | 2.2 B |
| P/E | 27.51 | 15.7 | 18.484 | 26.824 | 7.993 |
| P/S | 4.227 | 3.724 | 4.455 | 4.339 | 3.631 |
| Revenue USD | 50.1 B | 53.1 B | 48.6 B | 49.8 B | 52.8 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|